Wulan Li

878 total citations
41 papers, 742 citations indexed

About

Wulan Li is a scholar working on Molecular Biology, Organic Chemistry and Molecular Medicine. According to data from OpenAlex, Wulan Li has authored 41 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 13 papers in Organic Chemistry and 7 papers in Molecular Medicine. Recurrent topics in Wulan Li's work include Fibroblast Growth Factor Research (10 papers), Synthesis and biological activity (8 papers) and Curcumin's Biomedical Applications (7 papers). Wulan Li is often cited by papers focused on Fibroblast Growth Factor Research (10 papers), Synthesis and biological activity (8 papers) and Curcumin's Biomedical Applications (7 papers). Wulan Li collaborates with scholars based in China, Australia and Czechia. Wulan Li's co-authors include Jianzhang Wu, Peihong Qiu, Da Xu, Jiabing Wang, Guang Liang, Liping Chen, Jingwen Xie, Di Yun, Min Zhu and Wenfei He and has published in prestigious journals such as International Journal of Molecular Sciences, Experimental Cell Research and European Journal of Medicinal Chemistry.

In The Last Decade

Wulan Li

38 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wulan Li China 16 387 252 145 63 55 41 742
Gaurav Parashar India 14 379 1.0× 55 0.2× 45 0.3× 96 1.5× 72 1.3× 26 597
Naveen Kumar Vishvakarma India 16 309 0.8× 33 0.1× 113 0.8× 55 0.9× 201 3.7× 37 705
Thikryat Neamatallah Saudi Arabia 18 301 0.8× 200 0.8× 16 0.1× 73 1.2× 65 1.2× 41 865
Mann‐Jen Hour Taiwan 18 436 1.1× 531 2.1× 40 0.3× 77 1.2× 76 1.4× 38 1.1k
Fengli Xu China 12 218 0.6× 69 0.3× 74 0.5× 45 0.7× 36 0.7× 14 464
Pranesh Kumar India 17 359 0.9× 103 0.4× 34 0.2× 68 1.1× 59 1.1× 56 807
Yali Zhang China 11 243 0.6× 70 0.3× 107 0.7× 38 0.6× 29 0.5× 22 493
Lijuan Chen China 16 474 1.2× 143 0.6× 27 0.2× 54 0.9× 92 1.7× 28 995
Yong Ai China 16 290 0.7× 165 0.7× 24 0.2× 58 0.9× 36 0.7× 31 664

Countries citing papers authored by Wulan Li

Since Specialization
Citations

This map shows the geographic impact of Wulan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wulan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wulan Li more than expected).

Fields of papers citing papers by Wulan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wulan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wulan Li. The network helps show where Wulan Li may publish in the future.

Co-authorship network of co-authors of Wulan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Wulan Li. A scholar is included among the top collaborators of Wulan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wulan Li. Wulan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Wenfei, Zhicheng Huang, Qiong Zhang, et al.. (2024). Discovery and evaluation of novel spiroheterocyclic protective agents via a SIRT1 upregulation mechanism in cisplatin-induced premature ovarian failure. Bioorganic & Medicinal Chemistry. 110. 117834–117834. 1 indexed citations
2.
Wu, Jianzhang, Ling Zeng, Zhenzhen Yang, et al.. (2024). Green synthesis of neuroprotective spirocyclic chalcone derivatives and their role in protecting against traumatic optic nerve injury. European Journal of Medicinal Chemistry. 280. 116933–116933. 1 indexed citations
3.
Gan, Xin, Yuna Wu, Mingming Jin, et al.. (2024). Synthesis and Anti-gastric Cancer Activity by Targeting FGFR1 Pathway of Novel Asymmetric Bis-chalcone Compounds. Current Medicinal Chemistry. 31(39). 6521–6541.
4.
Xie, Jingwen, Zhaojun Dong, Yuna Wu, et al.. (2024). Discovery of Pyroptosis-inducing Drugs and Antineoplastic Activitybased on the ROS/ER Stress/Pyroptosis Axis. Current Medicinal Chemistry. 31(30). 4880–4897. 4 indexed citations
5.
Yan, Wentao, Tao Wu, Hongliang Zhong, et al.. (2024). Enhanced diagnosis of thyroid-associated eye diseases based on deep learning: A novel triplet loss design strategy. Biomedical Signal Processing and Control. 100. 107161–107161. 3 indexed citations
6.
7.
Jiang, Liping, Бо Лю, Shengjie Hou, et al.. (2022). Discovery and evaluation of chalcone derivatives as novel potential anti-Toxoplasma gondii agents. European Journal of Medicinal Chemistry. 234. 114244–114244. 12 indexed citations
8.
He, Wenfei, Jingsong Wang, Jiafeng Zhang, et al.. (2021). Design, green synthesis, antioxidant activity screening, and evaluation of protective effect on cerebral ischemia reperfusion injury of novel monoenone monocarbonyl curcumin analogs. Bioorganic Chemistry. 114. 105080–105080. 14 indexed citations
9.
Chen, Qian, Min Zhu, Jingwen Xie, et al.. (2020). Design and Synthesis of Novel Nordihydroguaiaretic Acid (NDGA) Analogues as Potential FGFR1 Kinase Inhibitors With Anti-Gastric Activity and Chemosensitizing Effect. Frontiers in Pharmacology. 11. 518068–518068. 3 indexed citations
10.
Wu, Jianzhang, Liping Chen, Lei Fan, et al.. (2019). The discovery of potent and stable short peptide FGFR1 antagonist for cancer therapy. European Journal of Pharmaceutical Sciences. 143. 105179–105179. 2 indexed citations
11.
Li, Ge, Ya Zhao, Wenfei He, et al.. (2019). Design and Green Synthesis of Piperlongumine Analogs and Their Antioxidant Activity against Cerebral Ischemia-Reperfusion Injury. ACS Chemical Neuroscience. 10(11). 4545–4557. 22 indexed citations
12.
Zhang, Jun, et al.. (2019). An efficient Legendre–Galerkin spectral element method for the steady flows in rectangular cavities. International Journal of Computer Mathematics. 97(9). 1806–1818. 1 indexed citations
13.
Chen, Liping, Zhaojun Dong, Ya Zhao, et al.. (2019). Piperlongumine analogue L50377 induces pyroptosis via ROS mediated NF-κB suppression in non-small-cell lung cancer. Chemico-Biological Interactions. 313. 108820–108820. 48 indexed citations
14.
Huang, Lili, Jiabing Wang, Liping Chen, et al.. (2017). Design, synthesis, and evaluation of NDGA analogues as potential anti-ischemic stroke agents. European Journal of Medicinal Chemistry. 143. 1165–1173. 33 indexed citations
15.
Wu, Jianzhang, Xiaojing Du, Wulan Li, et al.. (2017). A novel non-ATP competitive FGFR1 inhibitor with therapeutic potential on gastric cancer through inhibition of cell proliferation, survival and migration. APOPTOSIS. 22(6). 852–864. 10 indexed citations
16.
Wu, Jianzhang, Rong Jin, Yiqun Xia, et al.. (2016). Da0324, an inhibitor of nuclear factor-κB activation, demonstrates selective antitumor activity on human gastric cancer cells. Drug Design Development and Therapy. 10. 979–979. 23 indexed citations
17.
Wu, Jianzhang, Shanshan Zhang, Song Yao, et al.. (2016). Design, synthesis, and evaluation of asymmetric EF24 analogues as potential anti-cancer agents for lung cancer. European Journal of Medicinal Chemistry. 125. 1321–1331. 38 indexed citations
18.
Ying, Shilong, Xiaojing Du, Weitao Fu, et al.. (2016). Synthesis, biological evaluation, QSAR and molecular dynamics simulation studies of potential fibroblast growth factor receptor 1 inhibitors for the treatment of gastric cancer. European Journal of Medicinal Chemistry. 127. 885–899. 19 indexed citations
19.
Wu, Jianzhang, Tao Wei, Qinqin Tang, et al.. (2015). Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancer. BMC Cancer. 15(1). 276–276. 14 indexed citations
20.
Zhao, Chengguang, Yuepiao Cai, Jianling Li, et al.. (2010). Synthesis and anti-inflammatory evaluation of novel mono-carbonyl analogues of curcumin in LPS-stimulated RAW 264.7 macrophages. European Journal of Medicinal Chemistry. 45(12). 5773–5780. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gaurav Parashar Breakdown of academic impact, for papers by Naveen Kumar Vishvakarma Breakdown of academic impact, for papers by Thikryat Neamatallah Breakdown of academic impact, for papers by Mann‐Jen Hour Breakdown of academic impact, for papers by Fengli Xu Breakdown of academic impact, for papers by Pranesh Kumar Breakdown of academic impact, for papers by Yali Zhang Breakdown of academic impact, for papers by Lijuan Chen Breakdown of academic impact, for papers by Yong Ai
Rankless by CCL
2026